Dacarbazine and Pulmonary embolism - a phase IV clinical study of FDA data

Summary:

Pulmonary embolism is reported as a side effect among people who take Dacarbazine (dacarbazine), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Vinblastine Sulfate, and have Hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Pulmonary embolism when taking Dacarbazine. It is created by eHealthMe based on reports of 8,052 people who have side effects when taking Dacarbazine from the FDA, and is updated regularly.

What is Dacarbazine?

Dacarbazine has active ingredients of dacarbazine. eHealthMe is studying from 8,064 Dacarbazine users. Check the latest studies of Dacarbazine.

What is Pulmonary embolism?

Pulmonary embolism (blockage of the main artery of the lung) is found to be associated with 2,335 drugs and 2,959 conditions by eHealthMe. Check the latest studies of Pulmonary embolism.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 23, 2026

8,052 people reported to have side effects when taking Dacarbazine.
Among them, 77 people (0.96%) have Pulmonary embolism.

Could Dacarbazine cause Pulmonary embolism?

Among these 77 people:

How long have people been on Dacarbazine when they have Pulmonary embolism? *

What is the gender of people who have Pulmonary embolism when taking Dacarbazine? *

female: 43.33 %
male: 56.67 %

What is the age of people who have Pulmonary embolism when taking Dacarbazine? *

What are other drugs people take besides Dacarbazine? *

What are other side effects people have besides Pulmonary embolism? *

Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 13 people, 16.88%
Pneumonia: 9 people, 11.69%
Nausea (feeling of having an urge to vomit): 9 people, 11.69%
Weakness: 8 people, 10.39%
Disease Progression: 8 people, 10.39%
Thrombosis (formation of a blood clot inside a blood vessel): 7 people, 9.09%
Cytolytic Hepatitis (dissolution or destruction of a liver cell): 7 people, 9.09%
Pelvic Venous Thrombosis (blood clot occurring inside a blood vessel and thromboses (dvts) that form in the deep veins of the legs or in the pelvic veins): 6 people, 7.79%
Lung Disorder (lung disease): 6 people, 7.79%
Stomatitis (inflammation of mucous membrane of mouth): 6 people, 7.79%

What are the existing conditions these people have? *

Hodgkin's Lymphoma (cancer originating from white blood cells): 28 people, 36.36%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 15 people, 19.48%
Pain: 7 people, 9.09%
Malignant Melanoma (skin cancer rises from melancytes): 7 people, 9.09%
Constipation: 7 people, 9.09%
Stress And Anxiety: 7 people, 9.09%
Sarcoma (rare cancers that develop in the muscle, bone, nerves, cartilage, tendons, blood vessels and the fatty and fibrous tissues): 4 people, 5.19%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 2.60%
Embolism Venous (embolus may pass into the arterial system): 2 people, 2.60%
Hiv Infection: 2 people, 2.60%

* Approximation only. Some reports may have incomplete information.

Do you take Dacarbazine and have Pulmonary embolism?

- Check whether Pulmonary embolism is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dacarbazine:

Dacarbazine (8,064 reports)

Browse all side effects of Dacarbazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pulmonary embolism:

Pulmonary embolism (2,335 drugs)

Browse all the conditions that are associated with Pulmonary embolism:

Pulmonary embolism (2,959 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dacarbazine (the active ingredients of Dacarbazine) and Dacarbazine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.